Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon May 30, 2022 3:35pm
134 Views
Post# 34717906

RE:RE:RE:TSX Uplisting Expectations

RE:RE:RE:TSX Uplisting ExpectationsWell you need to know what the readership of the sites that news was posted to is. If you look at their twitter pages etc, I have more followers than most of them. 


So let's talk about the larger cell pouch. Why is it taking a year to design a larger pouch? Isn't scaleable one of the most used descriptors used by Spill when talking about it next to vascularized? How exactly is it scaleable if it takes a year to change the size of one? 


Instead of waiting for the golden ticket, it'd be nice if we got a bronze ticket or a silver ticket for the time being. The risk becomes greater and greater of failure as time goes on and we aren't rewarded with what has been done to date. We should be at least 2 dollars with the current results. The last thing you want to be involved with is something that has a binary result and this is turning into that.
<< Previous
Bullboard Posts
Next >>